Other
Fair Value Of Net Assets Acquired In Connection With Eqrx Acquisition
This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementCash Flow Statement
SectionOther
CategoryCapital Allocation
SignalHigher is better
VolatilityVolatile
First reportedQ1 2021
Last reportedQ4 2025Feb 25, 2026
How to read this metric
Reflects the scale and quality of assets acquired; higher values indicate a larger inorganic expansion of the company's resource base.
Detailed definition
This metric quantifies the fair market value of the assets and liabilities assumed during an acquisition. It provides in...
Peer comparison
Varies significantly based on the size and frequency of M&A activity within the pharmaceutical sector.
Metric ID:
other_fair_value_of_net_assets_acquired_in_connection_wi_d04362Historical Data
5 years
| FY'21 | FY'22 | FY'23 | FY'24 | FY'25 | |
|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $291.48M | $0.00 | $0.00 |
| YoY Change | — | — | — | -100.0% | — |
Range$0.00 – $291.48M
Avg YoY Growth-100.0%
Median YoY Growth-100.0%
Fair Value Of Net Assets Acquired In Connection With Eqrx Acquisition at Other Companies
Frequently Asked Questions
- What is Revolution Medicines, Inc.'s fair value of net assets acquired in connection with eqrx acquisition?
- Revolution Medicines, Inc. (RVMD) reported fair value of net assets acquired in connection with eqrx acquisition of $0.00 in Q4 2025.
- What does fair value of net assets acquired in connection with eqrx acquisition mean?
- The total value of assets and liabilities acquired through a business purchase.